Court Affirms Rejection Of "Aspirina" Mark

Law360, New York (May 25, 2007, 12:00 AM EDT) -- A federal appeals court panel has affirmed an examining attorney’s decision to deny Bayer AG’s “Aspirina” trademark in the United States.

In a 2-1 decision handed down Thursday, the U.S. Court of Appeals for the Federal Circuit agreed that Aspirina meant aspirin in Spanish, and that the proposed mark was therefore merely descriptive for analgesic goods.

“The appearance and meaning of Aspirina and aspirin are similar,” Judge Kimberly Moore wrote for the court. “Adding an ‘a’ to aspirin results in virtually no distinction with respect to...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.